Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis.
Saved in:
| Title: | Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis. |
|---|---|
| Authors: | Elkhooly M; Department of Neurology, Southern Illinois University School of Medicine, Springfield, IL, USA., Jacob R; Department of Neurology, College of Medicine, University of Florida, Gainesville, USA., Rempe T; Department of Neurology, College of Medicine, University of Florida, Gainesville, USA. |
| Source: | Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2026 Mar 24; Vol. 12 (1), pp. 20552173261432453. Date of Electronic Publication: 2026 Mar 24 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Ltd Country of Publication: United States NLM ID: 101668877 Publication Model: eCollection Cited Medium: Print ISSN: 2055-2173 (Print) Linking ISSN: 20552173 NLM ISO Abbreviation: Mult Scler J Exp Transl Clin Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2055-2173 |
|---|---|
| DOI: | 10.1177/20552173261432453 |
